Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
acute myeloid leukemia (AML)
Biotech
After a tough year, VBL merges with Notable Labs
After a rocky 2022 for VBL Therapeutics, the biotech is merging with cancer-focused platform company Notable Labs.
Gabrielle Masson
Feb 23, 2023 11:26am
Magenta halts group in leukemia trial after serious side effects
Dec 20, 2022 3:29pm
Sellas retunes AML trial as patients live longer than expected
Nov 14, 2022 12:56pm
Cyclacel passes phase 3 leukemia drug rights back to Daiichi
Nov 10, 2022 10:05am
Curis cuts staff as pending data hint at FDA application
Nov 10, 2022 6:15am
Kronos blames enrollment troubles for ending phase 3 AML program
Nov 9, 2022 8:19am
